Arnab Nayak

945 citations
24 papers · 724 indexed · h-index 14
Topics
Ubiquitin and proteasome pathways (9 papers)Muscle Physiology and Disorders (7 papers)Peptidase Inhibition and Analysis (5 papers)
Partner nations
GermanyItalyJapan

In The Last Decade

Arnab Nayak

22 papers receiving 721 citations

Peers

Arnab Nayak
Comparison fields: 5 of 76
  • Molecular Biology 529
  • Immunology 165
  • Oncology 149
  • Cell Biology 90
  • Epidemiology 81
Replace Matthew D. Smith with:
Matthew D. Smith United States
Khalid Ouararhni France
Tadashi Anan Japan
Guido Boehmelt Austria
Nathan W. Pierce United States
Ben G. Wen United States
Tiffany A. Melhuish United States
Mary Shen United States
Christopher S. Bland United States
Laìa Masvidal Sweden
Arnab Nayak relative to Matthew D. Smith United States Matthew D. Smith's profile →
Citations per field
00.5×1.5×2.4×
Matthew D. Smith · 1×
Citations per year

Countries citing papers authored by Arnab Nayak

Since Specialization
Citations

This map shows the geographic impact of Arnab Nayak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnab Nayak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnab Nayak more than expected).

Fields of papers citing papers by Arnab Nayak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnab Nayak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnab Nayak. The network helps show where Arnab Nayak may publish in the future.

Co-authorship network of co-authors of Arnab Nayak

This figure shows the co-authorship network connecting the top 25 collaborators of Arnab Nayak. A scholar is included among the top collaborators of Arnab Nayak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnab Nayak. Arnab Nayak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 9
5 2
6 10
7 9
8 15
9 17
10 8
11 21
12 13
13 21
14 25
15 58
16 27
17 61
18 69
19 83
20 15

About Arnab Nayak

Arnab Nayak is a scholar working on Molecular Biology, Virology and Immunology, having authored 24 papers that have together received 724 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (9 papers), Muscle Physiology and Disorders (7 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Immunology (165 citations), Molecular Biology (529 citations) and Cell Biology (90 citations). Arnab Nayak has collaborated with scholars based in Germany, Italy and Japan. Frequent co-authors include Stefan Müller, Mamta Amrute‐Nayak, Christian Morsczeck, Friederike Berberich‐Siebelt, Sandra Viale-Bouroncle, Julia Schümann, Judith Glöckner-Pagel, Martin Vaeth, Mathias Buttmann and Edgar Serfling. Their work appears in journals such as Journal of Biological Chemistry, Nano Letters and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026